Inventor
HARTIG PAUL R
US32 patents
⚠️ This page may combine multiple inventors who share the name “HARTIG PAUL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNAPTIC PHARMA CORP
28 patentsUS5360735ANov 1, 1994
DNA encoding a human 5-HT1F receptor, vectors, and host cells
SYNAPTIC PHARMA CORP98 citations97
US5661024AAug 26, 1997
DNA encoding a human serotonic (5-HT2) receptor and uses thereof
SYNAPTIC PHARMA CORP91 citations95
US5403847AApr 4, 1995
Use of α1C specific compounds to treat benign prostatic hyperlasia
SYNAPTIC PHARMA CORP70 citations95
US5595880AJan 21, 1997
DNA encoding an α2B adrenergic receptor and uses thereof
SYNAPTIC PHARMA CORP27 citations93
US6383762B1May 7, 2002
Methods of obtaining compounds that interact with a human serotonin (5-HT2) receptor
SYNAPTIC PHARMA CORP36 citations92
US6331401B1Dec 18, 2001
Uses of the 5-HT4 receptor
SYNAPTIC PHARMA CORP30 citations92
US6225115B1May 1, 2001
DNA encoding taurine and GABA transporters and uses thereof
SYNAPTIC PHARMA CORP33 citations92
US5935925AAug 10, 1999
Methods of treating migraine and compounds useful for such methods
SYNAPTIC PHARMA CORP23 citations92
US5885785AMar 23, 1999
DNA encoding a human serotonin (5-HT2) receptor and uses thereof
SYNAPTIC PHARMA CORP35 citations92
US5766879AJun 16, 1998
DNA encoding 5-HT4 serotonin receptors and uses thereof
SYNAPTIC PHARMA CORP18 citations92
US5658786AAug 19, 1997
DNA encoding rat taurine transporter and uses thereof
SYNAPTIC PHARMA CORP38 citations92
US5578611ANov 26, 1996
Use of α-1C specific compounds to treat benign prostatic hyperplasia
SYNAPTIC PHARMA CORP21 citations92
US5472866ADec 5, 1995
DNA encoding 5-HT4A serotonin receptors
SYNAPTIC PHARMA CORP20 citations92
US6468767B1Oct 22, 2002
DNA encoding a human dopamine D1 receptor and uses thereof
SYNAPTIC PHARMA CORP13 citations82
US5476782ADec 19, 1995
DNA encoding a human 5-HT1E receptor and uses thereof
SYNAPTIC PHARMA CORP15 citations82
US5882855AMar 16, 1999
DNA encoding a human dopamine D1 receptor and uses thereof
SYNAPTIC PHARMA CORP6 citations74
US5786155AJul 28, 1998
Methods for identifying a compound that binds to a human 5-HT 1E receptor
SYNAPTIC PHARMA CORP5 citations74
US5652113AJul 29, 1997
DNA encoding a human 5-HT 1F receptor and uses thereof
SYNAPTIC PHARMA CORP6 citations74
US5639652AJun 17, 1997
DNA encoding a human 5-HT1F receptor and uses thereof
SYNAPTIC PHARMA CORP4 citations74
US6015819AJan 18, 2000
Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
SYNAPTIC PHARMA CORP10 citations73
US5990128ANov 23, 1999
α1C specific compounds to treat benign prostatic hyperplasia
SYNAPTIC PHARMA CORP9 citations73
US5780485AJul 14, 1998
Use of α1c specific compounds to treat benign prostatic hyperplasia
SYNAPTIC PHARMA CORP13 citations73
US6475746B1Nov 5, 2002
Method of obtaining a composition comprising a 5-HT1D selective compound
SYNAPTIC PHARMA CORP1 citations63
US6406859B1Jun 18, 2002
DNA encoding a 5-HT 1F receptor and uses thereof
SYNAPTIC PHARMA CORP2 citations63
US6096507AAug 1, 2000
Methods for identifying a compound that binds to a human 5-HT1E receptor
SYNAPTIC PHARMA CORP3 citations63
US6127131AOct 3, 2000
DNA encoding a glycine transporter and uses thereof
SYNAPTIC PHARMA CORP2 citations62
US5756348AMay 26, 1998
DNA encoding a glycine transporter and uses thereof
SYNAPTIC PHARMA CORP5 citations62
US6602888B2Aug 5, 2003
Use of α1C specific compounds to treat benign prostatic hyperplasia
SYNAPTIC PHARMA CORP1 citations51